How long does it take for mirabegron (Mybetriq) to be cleared from the body after discontinuation in an adult with normal renal and hepatic function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mirabegron Clearance Time After Discontinuation

Mirabegron takes approximately 10-12 days (250-300 hours) to be essentially cleared from your system after stopping the medication in adults with normal kidney and liver function.

Pharmacokinetic Basis

The elimination of mirabegron is determined by its terminal half-life of approximately 50 hours 1. Using standard pharmacokinetic principles, a drug is considered essentially eliminated after 5 half-lives (when >97% is cleared from the body).

Calculation for complete clearance:

  • 5 half-lives × 50 hours = 250 hours (approximately 10.4 days)

Factors That Affect Clearance Time

Renal Function

Kidney function significantly impacts how long mirabegron remains in your system 1, 2:

  • Normal kidney function (eGFR ≥60): Standard 10-12 day clearance
  • Mild renal impairment (eGFR 60-89): Exposure increases by 31%, extending clearance to approximately 13-14 days
  • Moderate renal impairment (eGFR 30-59): Exposure increases by 66%, extending clearance to approximately 16-17 days
  • Severe renal impairment (eGFR 15-29): Exposure increases by 118%, potentially extending clearance to 21-23 days

Hepatic Function

Liver impairment also prolongs elimination 1, 2:

  • Mild hepatic impairment (Child-Pugh A): Minimal impact, clearance extends to approximately 11-13 days
  • Moderate hepatic impairment (Child-Pugh B): Exposure increases by 65%, extending clearance to approximately 16-17 days

Other Factors

  • Gender: Women have 40-50% higher exposure than men, though when adjusted for body weight, the difference is only 20-30% 1. This translates to approximately 1-2 additional days for complete clearance in women
  • Age: Elderly patients (≥65 years) have similar clearance times to younger adults 1

Clinical Implications

Symptom Resolution

Since mirabegron's therapeutic effects are directly related to plasma concentrations, OAB symptoms may begin to return within 2-3 days after stopping the medication (approximately 1 half-life), though residual effects persist for the full clearance period.

Blood Pressure Effects

The modest blood pressure increases associated with mirabegron (typically 0.5-1 mmHg) are reversible upon discontinuation 1. Blood pressure should normalize within the 10-12 day clearance window.

No Tapering Required

Unlike some medications, mirabegron does not require gradual dose reduction or "weaning". The drug can be stopped abruptly without withdrawal symptoms or rebound effects. The extended half-life provides a natural, gradual decline in drug levels.

Important Caveats

  • Renal clearance accounts for approximately 25% of total elimination 1, with 6-12% excreted unchanged in urine depending on dose
  • The remaining 75% is metabolized through multiple pathways (CYP3A4, CYP2D6, UGT, butyrylcholinesterase) 1
  • Individual variability exists; some patients may clear the drug slightly faster or slower than the average timeframe
  • If switching to another OAB medication, there is no mandatory washout period required given mirabegron's mechanism of action (β3-adrenergic agonist) differs from antimuscarinics

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.